Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kathleen Lutz"'
Autor:
Bobbie J. Rimel, Erin K. Crane, June Hou, John Nakayama, Jennifer MacDonald, Kathleen Lutz, Vicky Makker, Roisin E. O'Cearbhaill
Publikováno v:
Gynecologic Oncology. 174:148-156
Autor:
John P. Curtin, Zachary Schwartz, Melissa K. Frey, Julia Girdler, Erin Reese, Sarah S. Lee, Jessica Martineau, Kathleen Lutz, Bhavana Pothuri, Annie Olsen, Douglas A. Levine, Stephanie V. Blank, Deanna Gerber, Leslie R. Boyd, Emily Dalton
Publikováno v:
Gynecologic Oncology. 157:280-286
Background Timely genetic testing at ovarian cancer diagnosis is essential as results impact front line treatment decisions. Our objective was to determine rates of genetic counseling and testing with an expedited genetics referral pathway wherein wo
Publikováno v:
Gynecologic Oncology. 162:S326
Objectives: BRCA1/2 mutations increase cancer risk and may also confer risk for reduced fertility potential, posing a dilemma for BRCA mutation carriers desiring future fertility. On December 19, 2016, the FDA approved the use of Anti-Mullerian Hormo
Autor:
Jessica Martineau, Allison L. Brodsky, Julia Smith, Bhavana Pothuri, Ophira Ginsburg, Douglas A. Levine, Deanna Gerber, Katherine Baumann, Kathleen Lutz, Kristina Hwang
Publikováno v:
Journal of Clinical Oncology. 38:e13682-e13682
e13682 Background: We sought to evaluate the feasibility of obtaining genetic testing (GT) for first- or second-degree (1°, 2°) family members of a proband known to have actionable germline mutation associated with endometrial and/or ovarian cancer
Autor:
Leslie R. Boyd, Anne Olsen, John P. Curtin, Douglas A. Levine, Jessica Martineau, Melissa K. Frey, Zachary Schwartz, Sarah S. Lee, Stephanie V. Blank, Emily Dalton, Kathleen Lutz, Julia Girdler, Deanna Gerber, Bhavana Pothuri, Erin Reese
Publikováno v:
Journal of Clinical Oncology. 38:1584-1584
1584 Background: This study compared patient-reported stress, anxiety, and depression between newly diagnosed ovarian cancer patients with pathogenic genetic testing results versus patients with non-informative results (i.e., variants of uncertain si
Publikováno v:
Gynecologic Oncology. 154:161-162
Autor:
Fernanda Musa, Zacharia Sawaged, John P. Curtin, Jessica Lee, Leslie R. Boyd, Judith D. Goldberg, Erin Reese, Xiaochun Li, Stephanie V. Blank, Bhavana Pothuri, Kathleen Lutz, F. Muggia
Publikováno v:
Gynecologic Oncology. 154:247-248
Autor:
Bhavana Pothuri, Ana M. Franceschi, Kent Friedman, Zacharia Sawaged, Stephanie V. Blank, Kathleen Lutz, John P. Curtin, Melissa K. Frey
Publikováno v:
Journal of Clinical Oncology. 37:5569-5569
5569 Background: For patients with ovarian cancer undergoing neoadjuvant chemotherapy, the effectiveness of treatment is not evaluable by conventional methods until all or much of the treatment has been given. The purpose of this study is to investig
Publikováno v:
Molecular and Biochemical Parasitology. 175:1-9
The proteome of Eimeria bovis meront I-carrying host cells was analyzed by two-dimensional gel electrophoresis (2DE) at 14 days p.i. and compared to non-infected control cells. A total of 221 protein spots were modulated in their abundance in E. bovi
Publikováno v:
Veterinary Research Communications. 34:103-118
Host immune responses conducted against antigens of Eimeria bovis are key factors for the development of protective immunity against this protozoan disease. In this study we investigated the expression of E. bovis-derived antigens on the host cell su